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CT (ms) I (~) Sensibly (mV) 
Atrium: HI-5534 0.06 4. 0.04 1049±190 ° 3.8~- 1.6 
Atrium: G-5524 0.06 4. 0.07 523 4- 239 3.5 4.1.B 
Ventricle: H1-5034 O.O7 :l: 0.1 1178:E252" 13.2:E4.7" 
Ventricle: G-5024 0.07 4. 0.1 613 4. 93 12.1 4. 4.5 
*p .,. 0.05. HI vs. C 
Thus, HI leads are associated with lower calculated current drain and 
higher impedance in both the atrium and ventrfcie, and higher S in the 
ventricle. These results may be of clinical significance in extending the 
longevity of pacemaker pulse generators. 
CARDIAC TRANSPLANTATION-  BAS IC  AND CL INICAL 
~ Intimel Thickening Develops Without Humeral 
Immunity in • Mouse Aort ic  AIIograft Model of  
Chronic Vascular Rejection 
Lawrence H, Chow, Susanna Huh, Jifu Jiang, Necdet Ozcay, Robert Zhong, 
J. Geoffrey Pickering. Roberts Research Institute and University of Western 
Ontado, London, Canada 
Antidonor antibodies have been asSociated with the development of intimal 
thi*..kening inhuman allogralt coronary arteries, however acausal relationship 
has not been established. To determine if humeral immune responses are 
necessary for the development of graft vascular disease, we performed 
abdominal aortic allngrafts (inframnal aorta; end-to-and anastomosis) from 
normal donor mica into [mmunodeficient SCID mice (no T or B cell function), 
and into "knockout" mice without B cell function due to a targeted deletion 
of the joining region (J H) gone segments for the Ig heavy chain. Isograft 
controls (no rejection) and allegraft controls, both in normal recipient mice, 
were also performed. Unlike hetemtopi¢ heart grafts, the mouse aortic grefts 
are functional, load-bearing, free of the influence of growth factors from 
intmventricular lhrombus formation, and unaffected by acute cellular ejection 
of the myocardium. 
Results: 1) At 8-10 weeks post-transplant, isograft contrnls had a normal 
aspeadng vessel wall, except for !ccetized intimal thickening at the suture 
lines. 2) Allcgreft controls showed concentric intimalthickening, extending the 
full length of the graft. A propo~on of the ir~timal cells was immunoreactive for 
Thy-1 (T cells), CD4, CD8, and Mac-1 (macrophages), respec~valy. 3) Ago- 
grafts in immunndeticiant SCID mice showed a virtual absence of neointimal 
formation, except at the suture lines. 4) Allogrefts in J H-deteted mice without 
humeral immunity showed marked intimal thickening, indistinguishable from 
that of normal (immunocompetent) recipients. 
Conclusion: AIIograft intimal thickening is due to an allogsnaic immune 
response of the recipient, and is independent of the influence of humeral 
effector mechanisms. 
~ Capil lary Deposition of  C4d Complement 
Fragment: A New DtegnoMic Tool for  Humoral 
Rejection In Heart Transplant Recipients 
Thomas M. Behr, Klaus Richter, Petra Fischer, Chdstoph H. Spas, 
Bruno Meiser, Dieter Pongratz, Helmut Feucht, Kad Thalsen, Chdstiane 
E. Angermann. University of Munich, Germany 
Histological and immunohistological diagnosis of humeral rejection (HR) 
remains controversial. The classical pathway C1 q and C3c complement split 
products as well as IgG and IgM have been studied as markers of HR; 
however, their diagnostic value appears limited due to lack of specificity and 
their short endothelial adhesion time, C4d has been successfully used as an 
indicator of HR in human kidneys, but was never studied in Cardiac allografts. 
C4d Is covalantiy bound to the endothalium (disultid bddge); due to longer 
persistence, it should thus indicate HR more reliably in endomyocardial 
biopsies (EMB). To test this hypothesis, 16 patients were monitored with 
conventional histology (CH) & immunohietology(IH) for the first 3 months 
post cardiao transplantation (n = 38 satisfactory EMB), All patients received 
triple drug therapy including either FKS06 (n = 11) or cyciosporine A (n = 
5). With IH, the presence of C4d was compemd with Clq, C3c, IgG and 
IgM, Results: In none of the EMB, CH identified acute cellular rejection > IB 
(ISHL'r); laR was not suspected by CH in any of the EMB. 
EMB loG/M+ Glq+ C3c+ patientS morlaltty. 
C4d++ 9 6 3 5 6 50% (3)* 
C4d+l- 10119 16 2 9 10 0%* 
• Fisher exact p = P..036 
Patie~,';,, who died (1 graft failure, 2 sudden deaths within < 10 days of 
C4d++ EMB), had the most extensive deposition of C4d. These preliminary 
results suggest that extensive vascular deposition of CAd may be a new and 
more specific diagnostic marker for clinically significant HR. Patients with 
CAd++ seem to be at a high dsk to die shortly from either graft failure or 
sudden death. 
~ Impact of  Prophylact ic  Immediate Post-Transplant 
Ganciclovir on Development of Transplant 
Atherosclerosla: A Randomized 
Placebo-Control led Study 
Hannah A. Valentine, Shao-zhou Gas, Santosh Gopinathan, Dale 
G. Ranlund, Sharon A. Hunt, Thomas C, Medgan, Phi!!p _r"~,er, Edward 
B. Stinson, John S. Schroecier. Stanford University, Stanford, CA 
We have previously identified CMV disease as a significant predictor of trans- 
plant coronary disease ('rxCAD) and have reported a protective effect of dil- 
tiazem, We hypothesized that TxCAD is prevented by prophylactic treatment 
with ganciclovir, based on our controlled trial in which it Inhibited CMV dis- 
ease dudng the first 6 months alter heart ransplantation. Methods:The study 
population included 143 consecutive patients (125 men, 18 women aged 43 
± 13 years), d0uble-blinded and randomized to receive either ganciclovir 
or placebo during the initial 28 days after transplantation. Immunosuppres. 
sion consisted of OKT-3 prophylaxis and maintenance with ¢yclosperine (3- 
6 mg/kg/d), prednisane (0.1--1 mg/kg/d), and azathiopdne (2-4 mg/kg/d). 
Mean follow-up time was 3.7 4. 1.3 years. Using MantsI-Heonszet analysis 
we compared the actuarial incidence of TxGAD, defined by angiagraphy as 
the presence of any stenosis irrespective of severity, in patients stratified 
according to the use of calcium channel blockers. To determine whether 
ganciclovir use had an independent protective ffect against TxCAD, Cox re- 
gression analysis was performed, including donor age, calcium blocker use, 
and rejection episodes in) as potentially confounding co-vadatss. Results: 
TxCAD evaluation was unavailable in 23 patients due to early death or limited 
follow-up. 
Probability of Freedom From TxCAD (%) at 5 years 
DHPG No DHPG 
N % d~sease-free N % disease-free 
No Ca blower In = 54) 29 614.11 25 33:1:15 0.03 
Ca blocker (n = 66) 33 504.14 33 49"4-13 N.S 
By Cox regression analysis the only independent predictors of TxCAD were 
donor age > 40 years (relative risk = 2.7, confidence intervals = 1.3--5.7, p 
= 0.03), and no DHPG prophylaxis 0elative risk = 2.1, confidence intervals = 
1,1--4,1, p = 0.03). 
Conclusion: These data suggest hat ganciclovir protects against TxCAD in 
patients not treated with calcium blockers. Further studies in a larger sample 
are needed to determine the mechanism whereby ganciclovir influences the 
process of transplant atherosctsrosis. 
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~ Expression of  the AT1 Receptor in the Heart  
Fol lowing Myocardia l  Infarction (MI) 
Barry Gmenberg, Jay Ambrose, David Pribnow, Kalth Perkins, 
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Angictanain (A)it is believed tO play an important role in post-MI remodeling. 
All effects are mediated predomlnately through an interaction with Type I 
(AT1) receptors. To determine if expression of the AT1 receptor is altered 
post-MI and to localize changes within the heart, we assessed left ventricles 
(LV) of male Spregue-Dawley rats 5 days post left anterior descending coro- 
nary artery ligalion or sham operation. MI rats were either untreated (n = 6) or 
received 25 mg/kg/day enalapfil (n = 4), AT1 mRNA was quantitated by RT* 
PCR amplicatlon using an altered ATt cRNA as internal control. At a constant 
input RNA, the AT~ mRNA was increased from 0.11 ± 0.02 (mean :E SE) in 
controls (n = 5) to 1.47 4- 0.52 in post-MI rats (p < 0.05). In enalapdl treated 
MI rats the value was reduced to 0.55 4- 0.22 (13 = NS vs controls), Emul- 
sion autoradiography using z~l-Ait demonstrated increased AT1 receptor 
density which was localized to the peri-infaretion region. In situ hybddizution 
with an AT~ specific riboprobe confirmed this distribution. Non-myocyte cells 
with the appearance of fibroblasts appeared to be involved, These findings 
demonstrate that expression of the AT1 receptor is enhanced post MI and 
that the changes appear to involve cardiac fibmblaets in the pad-infarction 
region rather than cardiac myocytes. Since increased AT~ expression would 
augment RAS effects on cardiac remedeflng the attenuation with enalapril 
could explain some of the benefits of ACE Inhlbitors in this setting. 
